Table 1. Clinicopathologic features of patients and first-line treatment received for ovarian cancer.
| Characteristic | No. | Percent | Prognostic significance P-value |
|---|---|---|---|
| Number of patients |
471 |
100 |
|
| Age | 0.059 | ||
| Median age | 60.4 | ||
| Age range |
27–86 |
|
|
| First-line chemotherapy regimen |
|
|
0.04 |
| Platinum-based | 283 | 60.1 | |
| Platinum and taxane | 175 | 37.2 | |
| Other/none | 11 | 2.3 | |
| Unknown |
2 |
0.4 |
|
| Stage |
|
|
<0.0001 |
| I | 47 | 10.0 | |
| II | 56 | 11.9 | |
| III | 271 | 57.5 | |
| IV | 78 | 16.6 | |
| Unknown |
19 |
4.0 |
|
| Histology |
|
|
<0.0001 |
| Serous | 264 | 56.1 | |
| Clear cell | 24 | 5.1 | |
| Endometrioid | 94 | 20 | |
| Mixed | 61 | 13 | |
| MMMT | 0 | 0 | |
| Mucinous | 14 | 3.0 | |
| Other | 12 | 2.5 |
Abbreviation: MMMT=malignant mixed mesodermal tumor